Estradiol 20 mg pellet 99.5% Estradiol USP, .5% Stearic Acid NF in 1 count and 12 count bottles, ...
FDA Drug Recall #D-0891-2017 — Class II — April 19, 2017
Recall Summary
| Recall Number | D-0891-2017 |
| Classification | Class II — Moderate risk |
| Date Initiated | April 19, 2017 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Qualgen |
| Location | Edmond, OK |
| Product Type | Drugs |
| Quantity | 4,468 pellets. |
Product Description
Estradiol 20 mg pellet 99.5% Estradiol USP, .5% Stearic Acid NF in 1 count and 12 count bottles, Sterile Office Use Only, For Subcutaneous Use Only Rx Only, Manufactured by Qualgen 14844 Bristol Park Blvd Edmond, OK 73013 NDC: 69761-020-01
Reason for Recall
CGMP deviations- Lack of Quality Assurance
Distribution Pattern
Nationwide.
Lot / Code Information
Lot# C022; Exp. 08/21/17 Lot# B143; Exp. 11/22/17 Lot# B104; Exp. 09/27/17 Lot# B073; Exp. 08/1/17 Lot# B052; Exp. 06/13/17
Other Recalls from Qualgen
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0894-2017 | Class II | Estradiol 12.5 mg pellet 99.5% Estradiol USP, .... | Apr 19, 2017 |
| D-0895-2017 | Class II | Estradiol 10 mg pellet 99.5% Estradiol USP, .5%... | Apr 19, 2017 |
| D-0890-2017 | Class II | Estradiol 22 mg pellet 99.5% Estradiol USP, .5%... | Apr 19, 2017 |
| D-0892-2017 | Class II | Estradiol 18 mg pellet , 99.5% Estradiol USP, .... | Apr 19, 2017 |
| D-0889-2017 | Class II | Estradiol 25 mg pellet 99.5% Estradiol USP, .5%... | Apr 19, 2017 |
Frequently Asked Questions
cGMP stands for Current Good Manufacturing Practice — the FDA's regulations governing drug manufacturing quality. A cGMP recall means the company failed to follow required manufacturing standards. This could involve inadequate testing, poor environmental controls, documentation failures, or process deviations. cGMP recalls do not always mean the product is directly harmful — in many cases, quality records are insufficient to confirm the product meets specifications. However, the FDA requires a recall because without proper documentation, product quality cannot be assured. These are often Class II or Class III recalls.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.